Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Ella Pickover

New stomach cancer drug approved for NHS use in ‘first major advance’ in treatment in a decade

A new immunotherapy drug has been approved to treat stomach cancer - (Getty/iStock)

A new immunotherapy treatment for aggressive stomach cancer has been approved by the NHS spending watchdog.

The National Institute for Health and Care Excellence (Nice) has given the green light for the immunotherapy drug durvalumab, also known as Imfinzi and made by AstraZeneca, to be used by the NHS for adults whose stomach cancer has not spread extensively and can be surgically removed.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.